Texas Capital Gains Nearly 16% in 6 Months: Is It Worth Betting On?

Texas Capital Bancshares (TCBI) shares appreciated 15.8% over six months, outperforming the industry, fueled by 13.4% year-over-year NII growth in H1 2025, strategic expansion initiatives, and robust loan growth, supported by strong liquidity, capital ratios, and a $200 million share repurchase plan. While the bank is poised to benefit from anticipated Fed rate cuts, it faces near-term challenges from persistently rising non-interest expenses (42.2% CAGR 2020-2024) and deteriorating credit quality, particularly in multi-family and office real estate. Despite these headwinds, TCBI's favorable valuation and upwardly revised earnings estimates suggest potential for long-term returns.

Analysis

Texas Capital Bancshares (TCBI) has demonstrated significant market outperformance, with its stock appreciating 15.8% over the past six months, surpassing both the industry's 9% growth and the performance of peers BOKF and CFR. This momentum is underpinned by several fundamental strengths, including a 13.4% year-over-year increase in net interest income (NII) for the first half of 2025, which is poised to benefit further from recent Federal Reserve rate cuts. The bank's strategic initiatives are yielding tangible results, such as the acquisition of a $400 million healthcare loan portfolio and the expansion of its investment banking and direct lending capabilities. Loan growth remains robust, with the average loan portfolio increasing at a 4% CAGR from 2021-2024 and total average loans reaching $23.6 billion as of June 30, 2025. The balance sheet appears resilient, characterized by a common equity tier 1 (CET1) ratio of 11.4% and a substantial $200 million share repurchase program. However, these positive factors are counterbalanced by significant near-term risks. Non-interest expenses have surged at a 42.2% CAGR from 2020-2024 due to strategic investments, pressuring near-term profitability. More critically, credit quality is deteriorating, with non-performing assets and net charge-offs growing at CAGRs of 15.3% and 46.8% respectively from 2021-2024, a trend that continued into H1 2025, particularly within multi-family and office real estate loans. Despite these headwinds, the stock trades at a forward P/E of 12.9x, below the industry average, and consensus earnings estimates for 2025 have been revised upward, implying 39.3% growth.

Key Decisions for Investors

• Given the strong NII growth, strategic execution, and upward earnings revisions, investors with a higher risk tolerance might consider the stock for its long-term growth potential, especially as it trades at a slight valuation discount to the industry.
• Investors must closely monitor TCBI's upcoming quarterly reports for two key risk factors: any stabilization or decline in the growth rate of non-interest expenses and improvements in credit quality metrics, particularly net charge-offs and criticized assets in the commercial real estate portfolio.
• While the bank's capital return program is a positive, the deteriorating credit quality warrants caution; it may be prudent to size positions accordingly until there is clear evidence that asset quality pressures are abating.